Concerning ovarian cancer, Kleinberg et al. reported that XIAP and survivin are up-regulated in, respectively, effusions and metastasis of ovarian cancers, and could be considered to be targets and predictors of the patient outcomes36. Here, BIRC5 is linked to ovarian carcinoma.